Type 1 diabetes study in children and teens
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at the health records of children and teens newly diagnosed with type 1 diabetes to understand their insulin needs at the start and over the first year. It may help doctors better predict and manage insulin doses for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 14 years old or younger when first diagnosed with type 1 diabetes.
- Your diagnosis was made between January 2014 and December 2018 at the Pediatrics Unit of a specific hospital in Bologna, Italy.
- You have been followed by that same hospital for at least one year after diagnosis.
- Your parent or legal guardian has given permission for you to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a finger-prick test instead of a standard blood draw for the oral glucose tolerance test (OGTT), which measures how your body handles sugar. It may help young people at risk for or with early type 1 diabetes avoid repeated needle sticks.
This study looks at heart health in adults with type 1 diabetes. By joining, you'll help doctors better understand how to prevent heart problems in people like you.
This study builds a diabetes “registry” to better understand how diabetes is managed in children and teens. Your information helps create reference centers and improve care, and you must be willing to follow study instructions.
This study is looking for people with type 1 diabetes to better understand the condition and how it may be managed. You might qualify if you were diagnosed by a specialist and are insulin-dependent under certain conditions.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.